References
1a
Steel PG.
Chem. Commun.
1999,
2257
1b
Roush WR.
Barda DA.
Tetrahedron
Lett.
1997,
38:
8781
1c
Rossin R.
Jones PR.
Murphy PJ.
Worsley WR.
J. Chem.
Soc., Perkin Trans. 1
1996,
1323
1d
Pattenden GJ.
Fortsch. Chem. Org. Naturst.
1978,
35:
133
For leading references, see:
2a
Schobert R.
Siegfried S.
Synlett
2000,
686
2b
Sato T.
Koji Y.
Otera J.
Synlett
1995,
843
2c
Hoffmann HM.
Schmidt B.
Wolff S.
Tetrahedron
1989,
45:
6113 ; and references cited therein
3
Bajwa JS.
Anderson RC.
Tetrahedron Lett.
1990,
31:
6973
4
Tahir H.
Hindsgaul O.
J. Org. Chem.
2000,
65:
911
5
Martin SF.
Dodge JA.
Tetrahedron Lett.
1991,
32:
3017 ; and references cited therein
6 Analogous side reactions are well
known for Mitsunobu esterifications with hindered alcohols. For
a detailed mechanistic discussion, see: Hughes DL.
Reamer RA.
J.
Org. Chem.
1996,
61:
2967
7
Hendrickson JB. In Encyclopedia of Reagents for Organic Synthesis
Vol.
8:
Paquette LA.
Wiley;
Chichester:
1995.
p.5405
8
Hendrickson JB.
Singer M.
Hussoin MS.
J.
Org. Chem.
1993,
58:
6913
9
Typical Procedure
for the 4-O-Alkylation of Tetronic Acids:
To a stirred
solution of triphenylphosphine oxide (584 mg, 2.1 mmol) in CH2Cl2 (2
mL) at 0 °C was added dropwise trifluoromethanesulfonic
anhydride (168 µL, 1.0 mmol). After 15 min, when the reagent
had precipitated, a solution of tetronic acid (100 mg, 1.0 mmol)
and i-Pr2NEt (174 µL, 1.0
mmol) in CH2Cl2 (3 mL) was added. After the
colorless precipitate had dissolved, the respective alcohol (1.0-1.2 mmol)
was added dropwise, followed by i-Pr2NEt
(209 µL, 1.25 mmol). Then the reaction mixture was allowed
to warm to r.t. and stirred for 20 h, before it was concentrated
under reduced pressure. The crude product was purified by flash chromatography.
10
4-Methoxy-5
H
-furan-2-one
(
5a): Colourless crystals. Mp 48 °C
(Lit.:
[16]
63 °C). 1H
NMR (500 MHz, CDCl3): δ = 3.92 (s,
3 H, CH3), 4.64 (d, 2 H, J = 1.1
Hz, 5-H), 5.12 (t, 1 H, J = 1.1
Hz, 3-H).
4-Benzyloxy-5
H
-furan-2-one
(
5b): Colourless crystals. Mp 90 °C
(Lit.:
[16]
103-104 °C). 1H
NMR (400 MHz, CDCl3): δ = 4.65
(d, 2 H, J = 1.3
Hz, 5-H), 5.06 (s, 2 H, CH2O), 5.18 (t, 1 H, J = 1.3 Hz,
3-H), 7.35-7.44 (m, 5 H, Harom).
4-Allyloxy-5
H
-furan-2-one (
5c):
Colourless oil. IR(film): ν = 3123,
1778, 1745, 1627 cm-1. 1H
NMR (500 MHz, CDCl3): δ = 4.58
(dt, 2 H, J = 1.3,
5.8 Hz, CH2O), 4.66 (d, 2 H, J = 1.1
Hz, 5-H), 5.11 (t, 1 H, J = 1.1
Hz, 3-H), 5.40 (ddd, 1 H, J = 1.2,
2.4, 10.5 Hz, CH=CH
2),
5.43 (ddd, 1 H, J = 1.2, 3.1,
17.3 Hz, CH=CH
2),
5.98 (ddt, 1 H, J = 5.8,
10.5, 17.2 Hz, CH=CH2). 13C
NMR (125 MHz, CDCl3): δ = 67.9
(C-5), 73.2 (CH2O), 89.5 (C-3), 120.3 (CH=CH2), 130.2 (CH=CH2),
173.3 (C-2), 178.3 (C-4). MS (CI, CH5
+): m/z (%) = 141(100) [M + H+].
Anal. Calcd for C7H8O3 (140.1): C,
60.00; H, 5.75. Found: C, 59.98; H, 5.88.
4-Octyloxy-5
H
-furan-2-one
(
5d): Colourless oil. IR (KBr): ν = 3124,
1778, 1747 cm-1. 1H
NMR (400 MHz, CDCl3): δ = 0.82
(t, 3 H, J = 7.1
Hz, CH3), 1.16-1.39 (m, 10 H, CH2), 1.68-1.77
(q, 2 H, J = 6.7
Hz, CH
2CH2O), 3.99
(t, 2 H, J = 6.7
Hz, CH2O), 4.85 (d, 2 H, J = 1.1
Hz, 5-H), 5.38 (t, 1 H, J = 1.1
Hz, 3-H). 13C NMR (100 MHz, CDCl3): δ = 14.3 (C-8′),
22.6 (C-7′), 25.6 (C-3′), 28.4 (C-4′/C-5′),
29.1 (C-2′), 31.7 (C-6′), 67.9 (C-5), 73.1 (C-1′),
88.7 (C-3), 173.6 (C-2), 179.6 (C-4). MS (70 eV): m/z = 212 [M+].
Anal. Calcd for C12H20O3: C, 67.89;
H, 9.50. Found: C, 67.89; H, 9.58.
4-Isopropoxy-5
H
-furan-2-one
(
5e):
[17]
Colourless
oil. 1H NMR (500 MHz, CDCl3): δ = 1.39
(d, 6 H, J = 6.2
Hz, CH3), 4.44 (sept, 1 H, J = 6.2
Hz, CH), 4.60 (d, 2 H, J = 1.1
Hz, 5-H), 5.03 (t, 1 H, J = 1.1
Hz, 3-H). 13C NMR (100 MHz, CDCl3): δ = 21.3 [(CH3)2],
68.2 (C-5), 76.6 (CH), 88.5 (C-3), 173.9 (C-2), 178.3 (C-4).
(
R
)-4-(1-Methylheptyloxy)-5
H
-furan-2-one
(
5f): Colourless oil. [α]D
20 = +1.6
(c 1.08, CH2Cl2).
IR(film): ν = 3118, 2932, 2858,
1775, 1749, 1625 cm-1. 1H
NMR (500 MHz, CDCl3): δ = 0.89
(t, 3 H, J = 7.0
Hz, CH
3
CH2),
1.19-1.44 [m, 10 H, CH3(CH
2
)5],
1.35 (d, 1 H, J = 6.1
Hz, CH
3
CH),
1.61 (m, 1 H, CH
2
CH),
1.74 (m, 1 H, CH
2
CH), 4.27
(qt, 1 H, J = 6.1,
7.0 Hz, CH), 4.58 (dt, 1 H, J = 1.1, 16.4
Hz, 5-H), 4.63 (dt, 1 H, J = 1.1,
16.4 Hz, 5-H), 5.02 (t, 1 H, J = 1.1
Hz, 3-H). 13C NMR (100 MHz, CDCl3): δ = 14.0 (C-8′),
19.0 (C-1′), 22.8 (C-7′), 25.1 (C-4′),
29.0 (C-5′), 31.6 (C-6′), 35.6 (C-3′),
68.1 (C-5), 80.5 (C-2′), 88.3 (C-3), 174.0 (C-2), 178.7
(C-4). MS (CI, CH4): m/z = 213 [M + H+]. Anal.
Calcd for C12H20O3 (212.3): C,
67.89; H, 9.50; Found: C, 67.79; H, 9.76.
4-
tert
-Butoxy-5
H
-furan-2-one
(
5g): Colourless crystals. Mp 88-90 °C.
IR (KBr): ν = 3120, 1740, 1612
cm-1. 1H NMR (400
MHz, CDCl3): δ = 1.50
(s, 9 H, CH3), 4.55 (d, 2 H, J = 1.2
Hz, 5-H), 5.09 (t, 1 H, J = 1.2
Hz, 3-H). MS (CI, CH4): m/z = 157 [M + H+].
HRMS: m/z calcd for C8H13O3 [M + H+]:
157.0865. Found: 157.0832.
(
RS
)-4-Methoxy-5-methyl-5
H
-furan-2-one
(
5h): Colourless crystals. Mp 36 °C
(Lit.:
[18]
30-32 °C). 1H
NMR (500 MHz, CDCl3): δ = 1.46
(d, 3 H, J = 6.7
Hz, CH3), 3.89 (s, 3 H, OCH3), 4.83 (dq, 1
H, J = 0.9,
6.7 Hz, 5-H), 5.05 (d, 1 H, J = 0.9
Hz, 3-H). 13C NMR (100 MHz, CDCl3): δ = 17.8 (CH3),
59.5 (CH3O), 75.3 (C-5), 88.0 (C-3), 172.5 (C-2), 183.5
(C-4).
(
RS
)-4-Benzyloxy-5-methyl-5
H
-furan-2-one
(
5i): Colourless crystals. Mp 74 °C
(Lit.:
[16]
72 °C).
IR (KBr): ν = 3121, 2980, 1750,
1621 cm-1. 1H NMR
(500 MHz, CDCl3): δ = 1.49
(d, 3 H, J = 6.8
Hz, CH3), 4.88 (dq, 1 H, J = 0.9,
6.8 Hz, 5-H), 5.05 (d, 1 H, J = 11.6
Hz, CH2O), 5.08 (d, 1 H, J = 11.6
Hz, CH2O), 5.11 (d, 1 H, J = 0.9
Hz, 3-H), 7.35-7.45 (m, 5 H, Harom). MS (CI,
CH4): m/z = 205 [M + H+].
Anal. Calcd for C12H12O3 (204.2):
C, 70.58; H, 5.92. Found: C, 70.48; H, 5.82.
(
RS
)-4-Allyloxy-5-methyl-5
H
-furan-2-one
(
5j): Colourless oil. IR(film): ν = 3119,
1755, 1633 cm-1. 1H NMR
(500 MHz, CDCl3): δ = 1.48
(d, 3 H, J = 6.8
Hz, CH3), 4.55 (dt, 2 H, J = 1.4,
5.7 Hz, CH2O), 4.85 (q, 1 H, J = 6.8 Hz,
5-H), 5.04 (s
br
1 H, 3-H),
5.39 (ddd, 1 H, J = 1.0,
2.2, 10.4 Hz, CH=CH
2),
5.42 (ddd, 1 H, J = 1.1,
2.6, 17.3 Hz, CH=CH
2),
5.97 (ddt, 1 H, J = 5.7,
10.4, 17.3 Hz, CH=CH2). 13C
NMR (100 MHz, CDCl3): δ = 17.8
(CH3), 73.1 (CH2O), 75.4 (C-5), 88.8 (C-3),
120.1 (CH=CH2), 130.3
(CH=CH2), 172.5 (C-2),
182.0 (C-4). MS (CI, CH4): m/z = 155 [M + H+].
HRMS: m/z calcd for C8H10O3 (EI):
154.0630. Found: 154.0669.
11 Compound (S)-5f was prepared from butynoate 8 and (S)-2-octanol
as indicated in Scheme 4 according to a recently reported procedure.
The enantiomeric purity of this product (97.2% ee)12 was
almost equivalent to that of starting (S)-2-octanol
(97.6% ee): Paintner FF.
Metz M.
Bauschke G.
Synthesis
2002,
869
12 The enantiomeric purity of products 5f was determined indirectly. Successive
treatment of 5f with LiAlH4 (1.0 equiv,
THF, -78 °C to r.t.) and 0.01 M HCl (1.0
equiv, r.t.) afforded 2-octanol in 95% yield. Subsequent
derivatization with (S)-naproxen® chloride
(5 equiv, CH2Cl2, Δ) according to
Spahn led to the corresponding 2-octyl esters. The ratio of diastereomers
was determined by GC from the crude reaction product: Spahn H.
Arch. Pharm. (Weinheim, Ger.)
1988,
321:
847
13
Crich D.
Dyker H.
Tetrahedron Lett.
1989,
475
14
Maeda H.
Koide T.
Maki T.
Ohmori H.
Chem. Pharm. Bull.
1995,
43:
1076
15
Saylik D.
Horvath MJ.
Elmes PS.
Jackson WR.
Lovel CG.
Moody K.
J.
Org. Chem.
1999,
64:
3941
16
Pollet P.
Gelin S.
Tetrahedron
1978,
34:
1453
17
Zimmer H.
Amer A.
Pham CV.
Grob Schmidt D.
J. Org. Chem.
1988,
53:
3368
18
Gawronski JK.
Chen QH.
Geng Z.
Huang B.
Martin MR.
Mateo AI.
Brzostowska M.
Rychlewska U.
Feringa BL.
Chirality
1997,
9:
537